Real‐World Adverse Events Associated With the Sphere‐9 Dual‐Energy Arrhythmia Ablation Catheter
Journal of Cardiovascular Electrophysiology · 2026
DOI: 10.1111/jce.70367 ↗At a glance
Journal article in Journal of Cardiovascular Electrophysiology, 2026. Written by Ahmed Ashraf Morgan and 4 co-authors. Institution: Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, New York, USA. Major MEDLINE topics: Catheter Ablation, Cardiac Catheters, Atrial Fibrillation, Arrhythmias, Cardiac. Cited 3 times so far (Crossref); 20 references. The full text is freely available in PubMed Central.
Topics: Patientensicherheit
Abstract (original language)
Introduction
Sphere‐9 is a lattice tip ablation catheter (Medtronic, USA) capable of delivering both pulsed field and radiofrequency ablation. It is approved for the treatment of atrial fibrillation. Adverse events related to this device have been reported to national databases. A systematic assessment of these reports is needed to understand the nature of device‐related complications.
Methods
We queried the FDA Manufacturer and User Facility Device Experience (MAUDE) database between October 24, 2024 and October 24, 2025 to identify reports related to the Sphere‐9 catheter. A total of 222 reports were included in the final analysis.
Results
Of 222 reports, 148 (67%) resulted in clinical events. Of these, 107 were suspected to be related to the Sphere‐9, including: VT/VF during/following energy delivery ( n = 30), Stroke/TIA ( n = 25), sinus node dysfunction/AV block ( n = 23), pericardial effusion ( n = 7), coronary spasm ( n = 9), and phrenic nerve injury ( n = 2). Catheter/defibrillator (ICD) related interactions were suspected in 10 of the VT/VF reports. There were 65 catheter related reports that did not appear to be associated with adverse clinical events, which included tissue/char formation on the catheter tip ( n = 24), steam pop ( n = 25), and mechanical entrapment ( n = 7).
Conclusion
This early analysis of adverse events reported for the Sphere‐9 catheter highlights complications including arrhythmias, such as VT/VF and AV block, and the risks associated with ICD‐catheter related interactions.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, New York, USA.
- Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
ORCID profiles: Ahmed Ashraf Morgan, Suraj Adhikari
Cite
APA
Morgan, A. A., Adhikari, S., Alper, A., Faillace, R., & Kushnir, A. (2026). Real‐World Adverse Events Associated With the Sphere‐9 Dual‐Energy Arrhythmia Ablation Catheter. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70367
Vancouver
Morgan AA, Adhikari S, Alper A, Faillace R, Kushnir A. Real‐World Adverse Events Associated With the Sphere‐9 Dual‐Energy Arrhythmia Ablation Catheter. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70367
BibTeX
@article{Morgan2026,
author = {Morgan, Ahmed Ashraf and Adhikari, Suraj and Alper, Adir and Faillace, Robert and Kushnir, Alexander},
title = {Real‐World Adverse Events Associated With the Sphere‐9 Dual‐Energy Arrhythmia Ablation Catheter},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
doi = {10.1111/jce.70367}
}
EUVIMED